Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2017

View Archived Issues

ITUS enters research agreement with Moffitt Cancer Center

European Commission approves Tesaro's Zejula

Genexine's recombinant human erythropoietin effective in patients on dialysis

Selective nSMase2 inhibitor MS-882 shows promise for Alzheimer's disease

Orexo's Zubsolv approved for opioid dependence in Europe

FDA orphan and breakthrough therapy designations awarded to PellePharm for patidegib

FDA grants breakthrough therapy designation to patisiran

Indication for Zytiga expanded in Europe

FDA gives fast track status to lumateperone for treatment of schizophrenia

CX-549's neuroprotective effects demonstrated in a rat model of stroke

OphthaliX completes merger with Wize Pharma

FDA grants orphan drug designation to Revance's daxibotulinumtoxin A for cervical dystonia

Adocia reports phase I results for BioChaperone Glucagon

Melinta Therapeutics presents compounds for treating bacterial infections

Janssen applies to expand indication for Imbruvica in Japan

Novel glucosylceramidase activators presented by Lysosomal Therapeutics

Full U.S. commercial launch for Zilretta

Incyte discloses hPD-1 signaling inhibitors

First patient enrolled in pivotal study of Daiichi Sankyo's DS-8201

EMA announces relocation to the Netherlands

Calliditas Therapeutics gives update on phase III study plans for Nefecon

Calico Life Sciences and AbbVie patent new EIF2B activators

Bayer Pharma identifies vasopressin receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...